3.38
price down icon7.40%   -0.27
after-market アフターアワーズ: 3.41 0.03 +0.89%
loading
前日終値:
$3.65
開ける:
$3.7
24時間の取引高:
488.92K
Relative Volume:
1.41
時価総額:
$215.86M
収益:
$163.78M
当期純損益:
$25.88M
株価収益率:
5.20
EPS:
0.65
ネットキャッシュフロー:
$-28.66M
1週間 パフォーマンス:
-13.55%
1か月 パフォーマンス:
-17.16%
6か月 パフォーマンス:
-42.22%
1年 パフォーマンス:
-63.69%
1日の値動き範囲:
Value
$3.36
$3.7372
1週間の範囲:
Value
$3.36
$3.90
52週間の値動き範囲:
Value
$3.36
$10.66

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
名前
Voyager Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
857-259-5340
Name
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Name
職員
0
Name
Twitter
@VoyagerTx
Name
次回の収益日
2025-03-11
Name
最新のSEC提出書
Name
VYGR's Discussions on Twitter

VYGR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VYGR
Voyager Therapeutics Inc
3.38 215.86M 163.78M 25.88M -28.66M 0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Cantor Fitzgerald Overweight
2024-12-02 開始されました Citigroup Buy
2024-11-29 再開されました Wedbush Outperform
2024-10-16 開始されました Leerink Partners Outperform
2024-03-26 開始されました Guggenheim Buy
2024-03-19 開始されました H.C. Wainwright Buy
2024-03-07 開始されました Citigroup Buy
2024-01-02 アップグレード Wells Fargo Equal Weight → Overweight
2023-05-10 開始されました Truist Buy
2023-03-10 開始されました Oppenheimer Outperform
2021-10-07 アップグレード Robert W. Baird Neutral → Outperform
2021-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-03 ダウングレード BTIG Research Buy → Neutral
2021-02-03 ダウングレード Wedbush Outperform → Neutral
2020-12-24 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-12-23 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 ダウングレード Oppenheimer Outperform → Perform
2020-11-10 ダウングレード Raymond James Strong Buy → Outperform
2020-11-10 ダウングレード Wells Fargo Overweight → Equal Weight
2020-03-19 開始されました The Benchmark Company Buy
2020-02-06 開始されました Oppenheimer Outperform
2018-11-15 アップグレード Raymond James Outperform → Strong Buy
2018-09-10 再開されました BTIG Research Buy
2018-09-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-06-04 開始されました H.C. Wainwright Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-03-12 ダウングレード Wedbush Outperform → Neutral
2018-02-02 開始されました Morgan Stanley Overweight
2017-11-28 再開されました Piper Jaffray Overweight
2017-10-31 開始されました Robert W. Baird Outperform
2017-10-27 開始されました Canaccord Genuity Buy
2017-10-23 繰り返されました Stifel Buy
2017-10-12 開始されました Raymond James Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-28 再開されました Stifel Buy
すべてを表示

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
11:25 AM

Voyager Therapeutics Presents Promising Tau-Targeting Gene Therapy And Antibody Data At AD/PD 2025 - Nasdaq

11:25 AM
pulisher
10:00 AM

Voyager Therapeutics stock hits 52-week low at $3.54 By Investing.com - Investing.com UK

10:00 AM
pulisher
07:38 AM

Voyager reveals promising Alzheimer’s therapy data By Investing.com - Investing.com Australia

07:38 AM
pulisher
07:01 AM

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025 - GlobeNewswire

07:01 AM
pulisher
07:00 AM

New Alzheimer's Breakthrough: Single-Dose Gene Therapy Slashes Tau Levels by 73% - Stock Titan

07:00 AM
pulisher
Mar 19, 2025

Voyager Therapeutics at Virtual CNS Forum: Strategic Insights on Neurotherapeutics - Investing.com UK

Mar 19, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc.VYGR - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Voyager Therapeutics' (VYGR) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Mar 17, 2025
pulisher
Mar 15, 2025

Canaccord Genuity Group Cuts Voyager Therapeutics (NASDAQ:VYGR) Price Target to $12.00 - Armenian Reporter

Mar 15, 2025
pulisher
Mar 15, 2025

Voyager Therapeutics (NASDAQ:VYGR) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Voyager Therapeutics COO Robin Swartz sells $30,927 in stock - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $30 target on Voyager Therapeutics stock By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics’ Earnings Call Highlights Promising Future - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics stock hits 52-week low at $3.67 - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics stock hits 52-week low at $3.67 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics Inc earnings missed by $0.22, revenue fell short of estimates - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Earnings call transcript: Voyager Therapeutics Q4 2024 sees stock dip post-earnings - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Voyager Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Voyager Therapeutics: Strong Financials and Promising Pipeline Drive Buy Rating - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Voyager Therapeutics Q4 2024 sees stock dip post-earnings By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Therapeutics: Q4 Earnings Snapshot - mySA

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

VOYAGER THERAPEUTICS Earnings Results: $VYGR Reports Quarterly Earnings - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Therapeutics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire Inc.

Mar 11, 2025
pulisher
Mar 09, 2025

VOYAGER THERAPEUTICS Earnings Preview: Recent $VYGR Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 09, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Increases Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Voyager Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 04, 2025

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

John Stankey Updates Shareholders at Morgan Stanley Technology, Media & Telecom Conference on March 4 - The Globe and Mail

Mar 04, 2025
pulisher
Mar 04, 2025

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach - PharmaVoice

Mar 04, 2025
pulisher
Mar 04, 2025

When Will Voyager Therapeutics Reveal Its Latest Neurogenetic Medicine Progress? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Voyager Therapeutics (NASDAQ:VYGR) Given “Buy” Rating at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Voyager Therapeutics Reports Positive Data From Single Ascending Dose Study Of VY7523 - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Voyager Therapeutics Reports Positive Topline Data for VY7523 in Alzheimer’s Disease Trials - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Voyager Reports Positive Topline Data for Single Ascending - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Can Voyager's Anti-Tau Antibody Break Through in Alzheimer's Treatment? Phase 1 Results Show Promise - StockTitan

Mar 03, 2025
pulisher
Mar 02, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of “Buy” by Brokerages - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

Voyager Therapeutics stock hits 52-week low at $4 - Investing.com India

Feb 28, 2025
pulisher
Feb 27, 2025

Voyager Therapeutics stock hits 52-week low at $4 By Investing.com - Investing.com South Africa

Feb 27, 2025

Voyager Therapeutics Inc (VYGR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):